1226872-27-0
Chemical Structure
BTK-IN-3
- CAS. Nr.: 1226872-27-0
- Formula:C25H26N6O4
- Molecular Weight:474.51
IUPAC Name: 1-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)-2,3-dihydroxypropan-1-one
InChIKey: NWKPMPRXJGMTKQ-UHFFFAOYSA-N
SMILES: O=C(N1CC(N2N=C(C3=CC=C(OC4=CC=CC=C4)C=C3)C5=C(N)N=CN=C52)CCC1)C(O)CO
Biological Activity: BTK-IN-3 (example 1) is an inhibitor of BTK. BTK-IN-3 can used to study cancer[1].
| Art. -Nr. | Produktname | Reinheit | Beschreibung | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
BTK-IN-3 | BTK-IN-3 (example 1) is an inhibitor of BTK. BTK-IN-3 can used to study cancer. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Dihydrodiol-Ibrutinib-d5 | Dihydrodiol-Ibrutinib-d5 is the deuterium labeled Dihydrodiol-Ibrutinib (HY-100659). Dihydrodiol-Ibrutinib is a dihydrodiol active metabolite of Ibrutinib (HY-10997), has inhibitory activity towards BTK approximately 15 times lower than that of ibrutinib. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Keywords